Form 4: Kewaunee Scientific VP of IT Reports Routine Stock Transactions

Mandar Ranade, VP of Information Technology at Kewaunee Scientific Corp, reported the acquisition of 2,966 common shares through restricted stock unit vesting and the subsequent disposition of 1,298 shares for tax purposes.

Summary

• Mandar Ranade, VP-Information Technology of Kewaunee Scientific Corp, reported changes in beneficial ownership of common stock.
• On June 30, 2025, Ranade acquired 2,966 shares of common stock at a price of $0, resulting from the vesting of restricted stock units.
• Following this acquisition, Ranade's direct beneficial ownership of common stock increased to 13,963 shares.
• On July 1, 2025, Ranade disposed of 1,298 shares of common stock at a price of $58.34 per share. This disposition was for tax purposes related to the vesting of restricted stock units.
• After the disposition, Ranade's direct beneficial ownership of common stock was 12,665 shares.
• The acquired shares originated from the vesting of FY23, FY24, and FY25 Restricted Stock Units.
• The FY23 RSU grant (June 29, 2022) vested 1,912 units, representing the final installment of service-based units.
• The FY24 RSU grant (June 28, 2023) vested 518 units, representing a service-based installment. This grant also includes performance-based units that depend on future goals.
• The FY25 RSU grant (June 28, 2024) vested 536 units, representing a service-based installment. This grant also includes performance-based units that depend on future goals.

Sentiment

Score: 5

Explanation: The document reports routine insider transactions related to equity compensation, including vesting of restricted stock units and subsequent share disposition for tax purposes. These are standard, expected events and do not indicate a significant positive or negative shift in company fundamentals or outlook.

Positives

• The vesting of restricted stock units indicates the achievement of service-based vesting conditions for the reporting person.
• The acquisition of 2,966 shares at a $0 cost basis increases the reporting person's equity stake in the company.

Negatives

• The disposition of 1,298 shares, valued at $58.34 per share, reduces the reporting person's direct common stock holdings, although this is a common practice for tax obligations related to RSU vesting.

Future Outlook

Future vesting of performance-based restricted stock units for FY24 and FY25 grants are contingent upon the achievement of specific performance goals over a three-year period and the reporting person's continued employment with the company. Service-based units for FY24 and FY25 grants will continue to vest in equal annual installments.

Industry Context

This Form 4 filing details routine insider transactions related to equity compensation, which is a standard practice across various industries for executive and key employee retention and incentivization. It does not provide specific insights into broader industry trends or competitive dynamics.

Stakeholder Impact

• Shareholders: The transactions represent a routine change in an officer's direct shareholdings, with a slight reduction due to tax-related sales. This is generally not expected to have a material impact on the broader shareholder base or share price.
• Employees: The vesting of RSUs demonstrates the company's ongoing equity compensation program, which can be a positive for employee retention and motivation.

Next Steps

• Continued vesting of service-based restricted stock units for FY24 and FY25 grants in future annual installments.
• Potential vesting of performance-based restricted stock units for FY24 and FY25 grants, contingent on achieving performance goals over a three-year period.

Key Dates

Keywords

KEWAUNEE SCIENTIFIC CORP, KEQU, SEC Form 4, insider trading, stock transactions, restricted stock units, RSU vesting, common stock, Mandar Ranade, officer transactions, equity compensation